Achieve Late Phase Success with Precision
Navigate your late phase journey with efficiency and comprehensive solutions
Contact us
Navigate complex Phase 2b-3 trials with scale and end-to-end solutions that propel your therapy towards market readiness. Precision for Medicine stands at the forefront of late phase clinical trials, offering scalability, full-service execution, and regulatory readiness to ensure your project's success.
Streamlining Success in Late Phase Trials
- Global CRO
- Patient Strategies
- Regulatory Approval
-
Precision Execution with Global Reach
Leverage Precision's full-service outsourcing (FSO) or functional service provider (FSP) solutions to execute your late-phase trials with unmatched efficiency. Our global reach and integrated lab capabilities provide a one-stop solution, delivering consistency and quality across all study sites.
-
Enhancing Trial Efficiency with Patient-Centric Approaches
Discover how Precision emphasizes patient engagement and the capability to conduct decentralized clinical trials (DCTs), reducing patient burden and improving enrollment. Our strategies are tailored to meet the unique needs of late-phase trials, ensuring high participation rates and diverse participant representation.
-
Navigating the Path to Market
With strategic regulatory planning and in-depth expertise with FDA and EMA submissions, Precision navigates the complex regulatory landscape, ensuring your study is positioned for approval. Engage our regulatory strategists to streamline your path to market.
Oncology expertise by indication
Rare disease expertise by therapeutic area
Partner with Precision for comprehensive late phase research solutions. Our global reach and local expertise ensure your pivotal studies are not just conducted, but are strategically navigated towards success
Proceed with PrecisionBroadening Horizons in Late Phase Trials
- Lab Services
- Precision Technologies
- Manufacturing Solutions
- IVD & CDX Regulatory
-
Precision Integrated Labs
In the realm of late-phase development, the nuanced role of biomarkers becomes increasingly pivotal. Precision’s specialty and central lab services adeptly handle biomarker analysis, patient stratification, and safety monitoring, delivering the high-quality, actionable data essential for late-phase trials. Dive deeper into how our lab solutions can propel your therapy’s late-stage success.
-
Harnessing Technology for Insightful Breakthroughs
Embrace the cutting-edge with Precision Technologies, where tools like Apostream, EpiontisID, and QuartzBio’s Biomarker Data Management redefine the scope of trial insights. With Virtual Sample Management and MetaVate, our technologies offer unparalleled depth to your data analysis, propelling your therapy’s journey with evidence-backed precision.
-
Navigating to Commercial Readiness
As your therapy edges closer to commercialization, the complexities of manufacturing demand a strategic approach. Precision’s Manufacturing Solutions, specializing in advanced therapies, ensure your journey from clinical scale to market readiness is both scalable and compliant, setting the stage for your therapeutic innovation’s successful launch.
-
Regulatory Mastery for IVD & CDx
With a century’s worth of combined expertise, Precision for Medicine’s IVD Regulatory Team offers unparalleled guidance for IVDs and Companion Diagnostics. Across continents and regulatory landscapes, we craft strategies that streamline global assay testing and registrations, ensuring your diagnostics meet global standards and accelerate your therapy's market entry.
Precision late phase resources
Discover our collection of resources designed to optimize and accelerate your late phase development.
View all resourcesExpanding your therapy's impact with Precision
Beyond clinical trials, Precision for Medicine extends your reach into health economics, market access, and medical communications to ensure your therapy achieves its fullest potential and commercial success.
Specialized capabilities in every stage of clinical development
Leverage an integrated infrastructure that reduces the inefficiencies inherent in complex development. Integrate lab and trial execution to increase speed to market. Incorporate manufacturing expertise for advances therapies to ensure scalability. Precision can customize and converge our capabilities for your program's unique needs.
-
Discover Explore
Global CRO
ServicesAward-winning CRO with deep oncology and rare disease expertise
-
Discover Explore
Global Laboratory
ServicesExceptional translational and biomarker sciences with global central lab services
-
Discover Explore
Manufacturing
SolutionsPioneers in planning, building and maintaining manufacturing at scale for pharma and biotechs.
-
Biospecimens
-
Diagnostics & CDx
-
Data Intelligence
-
Commercialization
Navigating late phase with Precision insights
Stay informed with the latest late phase and clinical trial insights from our experts, who share knowledge, trends, and success stories from the forefront of clinical research.
Clinical Trial Trends: Early Phase Rare Oncology
Pioneer new therapies with Precision expertise
With Precision, your pioneering treatments in Oncology, Rare Diseases, and beyond are propelled from concept to reality, supported by teams with deep domain expertise and innovative approaches.